Pre-Tax Income: Company's earnings or loss before taxes on income have been accounted for.
Rocket Pharmaceuticals, Inc. (RCKT) had Pre-Tax Income of $131.84M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$123.21M |
|
-- |
|
-- |
|
$46.92M |
|
$-46.92M |
|
$178.76M |
|
|
Pre-Tax Income |
$131.84M |
$131.84M |
|
$123.21M |
|
$123.21M |
|
$123.21M |
|
$123.21M |
|
$-46.92M |
|
$-44.82M |
|
112.84M |
|
114.51M |
|
$1.09 |
|
$1.08 |
|
| Balance Sheet Financials | |
$289.55M |
|
$25.10M |
|
$133.55M |
|
$423.10M |
|
$31.32M |
|
$19.33M |
|
$22.95M |
|
$54.27M |
|
$368.83M |
|
$304.53M |
|
$368.83M |
|
109.54M |
|
| Cash Flow Statement Financials | |
$-85.01M |
|
$231.81M |
|
$0.15M |
|
$78.90M |
|
$225.85M |
|
$146.95M |
|
$15.91M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.24 |
|
-- |
|
-- |
|
0.05 |
|
0.06 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-85.11M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
33.41% |
|
40.46% |
|
29.12% |
|
31.74% |
|
$3.37 |
|
$-0.74 |
|
$-0.74 |
|